IBM Gives Long-Term Sales Growth Outlook That Tops Expectations
International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the expansion in its software business.
Novo Nordisk Expects Slowing Sales Growth This Year
The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition and pricing pressure drag on sales of its blockbuster weight-loss and diabetes drugs.
Wegovy sales double but Novo Nordisk sees slower sales growth in 2025
Wegovy maker Novo Nordisk on Wednesday forecast sales would grow at a slower rate this year although the outlook was roughly in line with market expectations as the pace of ferocious demand for its wildly popular obesity drug Wegovy eases somewhat.
Novo Nordisk sales beat estimates, but the story wasn’t Ozempic
Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.
Novo Nordisk’s Wegovy Drug Sales Miss Expectations
The Danish pharmaceutical company’s blockbuster Wegovy weight-loss drug just missed sales expectations in the fourth quarter despite more than doubling on the year.
Novo Nordisk Q4 profit beats expectations, sees slower growth in 2025
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow that is likely to deepen investor concerns that the company is losing its edge in the competitive obesity market to rival Eli Lilly.
Novo Nordisk's posts net profit beat as Wegovy sales jump 107% in fourth quarter
Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs. Net profit for the fourth quarter came in at 28.
Zepbound sales keep soaring, even as weight loss drug growth slows
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s ...
Amazon profits last year soared, but growth is slowing
Amazon almost doubled its profits in 2024 compared to the year before, but it missed some analysts expectations in its cloud ...
Toyota likely to post second straight profit drop as sales growth cools
Japan's Toyota Motor is expected to post its second consecutive quarterly profit drop when it reports third-quarter earnings ...
Amazon Says Profits Rose 88% but Cautions Growth May Slow
The company’s cloud computing business showed strong growth, while a forecast for the current quarter disappointed investors.
AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China
Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...
Chipotle assesses fallout from Mexico tariffs, forecasts tepid annual sales growth
Chipotle Mexican Grill said on Tuesday that if President Donald Trump's proposed tariffs on Mexico go into full effect, the ...
Gilead: Strong Sales Growth Remains With Veklury And Beyond
Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
Yum! Brands Stock Shines After Q4 Earnings Beat, Fueled By Taco Bell and KFC Growth Engines
Yum! Brands, Inc. (NYSE:YUM) shares are trading higher on Thursday. The company reported fourth-quarter adjusted earnings per ...
L’Oreal Posts Increased Sales Despite Decline in China
The French beauty giant said its sales amounted to €43.48 billion in 2024, up 5.6% on-year and 5.1% on a like-for-like basis.
Canopy Growth: Still A Disaster Heading Into Fiscal Q3 Results
Be cautious ahead of Canopy Growth Corporation's FQ3 results, as weak financials and low margins may hinder stock performance ...